6 completed, 3 withdrawn, 1 terminated. 10 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 10 | Completed 6, Withdrawn 3, Terminated 1 |
| Phase 1 | 1 | Completed 1 |
Follow Vulvovaginal Atrophy: new trials by email Literature Review of Vulvovaginal Atrophy trials Research Report on Vulvovaginal Atrophy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of DARE-HRT1 Over 12 Weeks in Healthy PostMenopausal Women IVR Dose 1, IVR Dose 2 - Vulvovaginal Atrophy, Vasomotor Symptoms | Phase 1 / Phase 2 | Completed | Daré Bioscience, Inc. | 21 | 2022-04-11 | 2024-10-31 |
| Photobiomodulation Effect on Vulvovaginal Atrophy in Postmenopausal Women. Estrogen vaginal cream group (group A), Photobiomodutation group (group B) - Vulvovaginal Atrophy | Phase 2 | Withdrawn | University of Nove de Julho | 2020-12-15 | 2023-06-29 | |
| Investigation of Efficacy and Tolerability of a Lactic Acid Containing Vaginal Suppository in Post-menopausal Women With VVA WO533 - Vulvovaginal Atrophy | Phase 2 | Completed | Dr. August Wolff GmbH & Co. KG Arzneimittel | 43 | 2020-01-27 | 2021-12-23 |
| Carbon Dioxide Fractional Laser in Treating Participants With Stage 0-III Hormone Receptor-Positive Breast Cancer With Vulvovaginal Atrophy Carbon Dioxide Fractional Laser, Questionnaire Administration - Anatomic Stage 0 Breast Cancer AJCC v8, Anatomic Stage I Breast Cancer AJCC v8 | Phase 2 | Withdrawn | Mayo Clinic | 2018-09-10 | 2023-01-06 | |
| Sexual Penetration Pain in Postmenopausal Women: A Topical Botanical Drug Treatment 5% sinecatechins ointment, Placebo, 10% sinecatechins ointment - Sexual Pain Disorders, Postmenopausal Symptoms | Phase 2 | Terminated | GTO Pharmaceutical, LLC | 32 | 2018-08-30 | 2022-07-27 |
| Vaginal Progesterone Versus Placebo for the Treatment of Vaginal Atrophy Vaginal progesterone, Placebo - Atrophic Vaginitis, Menopause | Phase 2 | Withdrawn | Mount Sinai Hospital, Canada | 2016-12-01 | 2024-03-20 | |
| Visnadine, Prenylflavonoids and Bovine Colostrum to Treat Vulvovaginal Atrophy in Postmenopausal Women Visnadine, prenylflavonoids and bovine colostrum - Vulvovaginal Atrophy, Menopause | Phase 2 | Completed | University of Messina | 54 | 2016-12-01 | 2020-03-25 |
| Study to Evaluate Efficacy of Vagitocin in Postmenopausal Women With Vulvovaginal Atrophy Symptoms Oxytocin 400 IU vaginal gel, Placebo - Vulvovaginal Atrophy | Phase 2 | Completed | PepTonic Medical AB | 202 | 2016-05-03 | 2020-11-16 |
| A Safety and Efficacy Study of Estradiol Vaginal Capsule in Postmenopausal Women With Vulvovaginal Atrophy Estradiol Vaginal Capsule (EVC), Placebo - Vulvovaginal Atrophy, Menopause | Phase 2 | Completed | Warner Chilcott | 203 | 2016-02-15 | 2017-08-23 |
| TXV13-01 Estradiol Vaginal Softgel Capsules in Treating Postmenopausal Women With Symptoms of Vulvar and Vaginal Atrophy Estradiol, placebo - Menopause, Vulvovaginal Atrophy | Phase 2 | Completed | TherapeuticsMD | 50 | 2013-07-01 | 2015-12-14 |
Dyspareunia (4) · Atrophic Vaginitis (1) · Breast Carcinoma In Situ (1) · Sexual Dysfunctions, Psychological (1) · Vulvodynia (1)
Female Urogenital Diseases (5) · Female Urogenital Diseases and Pregnancy Complications (5) · Genital Diseases (5) · Genital Diseases, Female (5) · Urogenital Diseases (5) · Genital Diseases, Male (4) · Male Urogenital Diseases (4) · Mental Disorders (4) · Sexual Dysfunction, Physiological (4) · Sexual Dysfunctions, Psychological (3) · Breast Diseases (1) · Breast Neoplasms (1) · Carcinoma (1) · Carcinoma in Situ (1) · Neoplasms (1)
Estradiol (1) · Oxytocin (1) · Petrolatum (1) · Vaginal Creams, Foams, and Jellies (1) · polyphenon E (1) · visnadin (1)
DarĂ© Bioscience, Inc. (1) · Dr. August Wolff GmbH & Co. KG Arzneimittel (1) · GTO Pharmaceutical, LLC (1) · Mayo Clinic (1) · Mount Sinai Hospital, Canada (1) · PepTonic Medical AB (1) · TherapeuticsMD (1) · University of Messina (1) · University of Nove de Julho (1) · Warner Chilcott (1)
United States (3) · Australia (1) · Canada (1) · Germany (1) · Sweden (1)
Aino Fianu Jonasson, MD (1) · Kirstin Deuble-Bente, MD (1) · Lila Nachtigall, M.D. (1) · Salvatore Giovanni Vitale, M.D. (1) · Saranya Chumsri (1) · Shelli Graham, PhD (1) · Vilma Sniukiene, MD (1) · Wendy L Wolfman, MD, FRCSC (1)
PMID 36787527, PMID 37339390, PMID 37619252, PMID 37625088
2016 (1), 2019 (1)